Unknown

Dataset Information

Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.


ABSTRACT:

Background

Data are limited on the benefits and risks of dose reduction in managing side effects associated with antipsychotic treatment. As an example, antipsychotic dose reduction has been recommended in the management of tardive dyskinesia (TD), yet the benefits of lowering doses are not well studied. However, stable maintenance treatment is essential to prevent deterioration and relapse in schizophrenia.

Methods

A retrospective cohort study was conducted to analyze the healthcare burden of antipsychotic dose reduction in patients with schizophrenia. Medical claims from six US states spanning a six-year period were analyzed for ≥10% or ≥ 30% antipsychotic dose reductions compared with those from patients receiving a stable dose. Outcomes measured were inpatient admissions

SUBMITTER: Caroff SN 

PROVIDER: S-EPMC6154822 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature